This article has Open Peer Review reports available.
Dermoscopy as an adjuvant tool for detecting skin leiomyomas in patient with uterine fibroids and cerebral cavernomas
- Laura Diluvio1Email author,
- Claudia Torti1,
- Alessandro Terrinoni2,
- Eleonora Candi2,
- Raffaella Piancatelli3,
- Emilio Piccione3,
- Evelin Jasmine Paternò4,
- Sergio Chimenti1,
- Augusto Orlandi5,
- Elena Campione†1 and
- Luca Bianchi†1
© Diluvio et al.; licensee BioMed Central Ltd. 2014
Received: 4 January 2014
Accepted: 2 April 2014
Published: 16 April 2014
Hereditary syndromes frequently need the cooperation of different specialties to increase diagnostic competence. Multiple cutaneous and uterine leiomyomatosis syndrome is a rare autosomal dominant disorder caused by the mutations of the fumarate hydratase gene, demonstrated in 80 to 100 percent of affected individuals. This can be linked to an increased risk of renal cancer in both sexes. The skin involvement is described to highlight the diagnostic role of the cutaneous counterpart in identifying this rare syndrome.
A 37-year-old woman suffering from several uterine fibroids presented multiple, painful, papulo-nodules on her left subscapular side, both forearms and legs. The patient underwent surgery on six lesions: five were leiomyomas, whilst one was a dermatofibroma. Genetic sequencing did not evidence known fumarate hydratase gene mutations. Dermoscopy showed a brown delicate pigmented network and included leiomyomas among the non-melanocytic benign skin tumours featuring a dermatofibroma-like pattern. Abdominal computerized-tomography scan did not reveal renal cancer, but brain magnetic resonance imaging showed one asymptomatic cerebral cavernoma. The patient benefited from the surgical removal of the five larger cutaneous lesions and from gabapentin, which relieved her pain.
This observation highlights the usefulness of dermoscopy in the diagnosis of cutaneous leiomyomas disclosing multiple cutaneous and uterine leiomyomatosis syndrome. Dermoscopy should be performed for non-melanocytic multiple lesions mimicking leiomyomas in a large number of patients, to establish a strict classification and identify false negative cases or evaluate them as dermatofibromas. In this case, the dermatologist recognized the risk of renal cancer and cerebral cavernomas.
Multiple cutaneous and uterine leiomyomatosis (MCUL), previously known as Reed's syndrome, is an autosomal dominant disease with incomplete penetrance characterized by the onset of uterine leiomyomas or fibroids and skin leiomyomas in both sexes [1, 2]. The coexistence of cutaneous and uterine leiomyomas may cluster papillary type2 renal-cell carcinoma or renal collecting duct cancer, codifying a recent variant appointed as hereditary leiomyomatosis and renal cell cancer (HLRCC) . Even though different gene mutations, missense, nonsense or whole gene deletions have been described in MCUL syndrome, a definite association between site or type of mutation and the risk of papillary renal-cell carcinoma has not been found yet . Cutaneous leiomyomas - accounting for 75% of all extra-uterine leiomyomas - are uncommon benign smooth muscle tumours deriving either from the erector pili muscle of the pilosebaceous unit (piloleiomyomas), the cutaneous vascular smooth muscle fibers (angioleiomyomas) or from the dartos muscle (genital leiomyomas) . Piloleiomyomas are the most common form and show firm, skin-colored or pink-brown soft dermal papules or nodules, ranging up to 2.0 cm in diameter, distributed in single, clustered, segmental or disseminated patterns. Linear or segmental leiomyomas may present a dermatomal-like distribution . Common locations include trunk, extensor surface of the extremities and face, more often in adulthood then in childhood. Neoplasms can be asymptomatic or quite debilitating and actually painful mainly in response to pressure or cold temperature . Clinical differential diagnoses include several skin lesions, such as dermatofibroma, eccrine spiradenoma, neurofibroma, angiolipoma, neurilemmoma, glomus tumour, keloid, hamartomas and blue rubber bleb nevus syndrome when painful, or dermal nevus, trichoepithelioma, lipoma, cylindroma or poroma among the asymptomatic tumours . The skin involvement of a case of MCUL syndrome is reported to support the diagnostic role of the cutaneous counterpart in identifying this rare syndrome. We present and discuss a case of multiple cutaneous lesions and the usefulness of dermoscopy for a better understanding of skin leiomyomas in the wide spectrum of non-melanocitic lesions.
Genetic analysis was performed using RNA extracted from a leiomyoma biopsy. Complete coding region sequencing of all 10 exons of Fumarate Hydratase gene (Gb #NM_000143) was evaluated using direct sequencing of RT-PCR amplified FH transcript. The sequence did not reveal nucleotide changes in coding region, due to the presence of amino acid substitutions. This does not exclude the possible presence of complex genomic mutations located inside introns, which could lead to abnormal transcripts. The level of enzymatic FH analysis should be investigated to further characterise the patients for FH activity depletion. Complete routine blood testing and urinalysis did not show anomalies. Abdominal computerized-tomography (CT) scan displayed uterine fibroids and normal appearing kidneys. Brain magnetic resonance imaging (MRI) showed one asymptomatic cerebral cavernoma (data not shown).
Hereditary syndromes frequently need the cooperation of different specialties, and MCUL/HLRCC disorder is a relevant example of this occurrence. The skin is often part of hereditary syndromes. Alongside the clinical and histological approach, we investigated if, in vivo, non-invasive, methods of investigations, dermoscopy or RCM, could increase our diagnostic skills. Cutaneous leiomyomas are dermal proliferations of benign smooth muscle fibres; in these cases, the diagnostic role of superficial investigations is regarded as possibly uncertain. A new interesting finding came from dermoscopy, which showed also leiomyomas among the non-melanocytic benign skin tumours featuring a dermatofibroma-like appearance. In all leiomyomas we observed a delicate pigment network with thin lines of pinkish-light brown colour and regular meshes, regularly distributed and gradually faded into the surrounding skin. The larger lesions could present vascular structures, although they were not representative for most piloleiomyomas (Figure 4). In some piloleiomyomas we documented masses of “white like-cloud” areas without translucent streaks, typical of the dermoscopic central scar-like patch in dermatofibroma (Figure 5). However, as also recently described by Paschoal, we did not see hyperpigmented circular and/or elongated structures within the central hypopigmented area .
The pigmented network pattern seems reasonably related to a reactive epidermal basal hyperpigmentation, as observed in the histologically confirmed lesions, due to the lower neoplastic growth of dermatofibroma and leiomyoma. RCM, as expected, did not give consistent results because of the deep dermal location of the proliferation.
Surprisingly, our patient presented also a dermatofibroma, characterized by a white scar like patch surrounded by a delicate pigment network (Figure 2); this gave us the opportunity to better distinguish the dermoscopic findings and to establish specific criteria for differential diagnosis . Before a pigmented network pattern of clinically non-melanocytic lesions, the dermoscopic differential diagnosis should consider seborrheic keratosis, solar lentigo, dermatofibroma, and supernumerary accessory nipple .
Although screening guidelines for MCUL/HLRCC syndrome have not been defined yet, Smit listed practical criteria to ensure an appropriate diagnostic approach . Suspected MCUL should always motivate a histological diagnosis of at least one cutaneous lesion. DNA analysis to test FH mutations should be recommended for all patients with familiar or severe cutaneous or uterine leiomyomatosis to eventually detect an occult renal malignancy, with genetic counselling in positive cases. Furthermore, since some mutations could not be detected via standard sequencing analysis, an accurate enzymatic test should be developed to verify FH activity in patient cells. An accurate follow-up should include annual cutaneous and gynaecological examinations for the risk of leiomyosarcoma, together with annual renal ultrasound investigations. Furthermore, since cerebral angiomatosis has been also described in MCUL patients, dermatologists and gynaecologists should consider the relative risk of cerebral haemorrhages through brain MRI . If in females coincident uterine fibroids with often multiple and segmental cutaneous leiomyomas suggest the diagnosis of MCUL syndrome, in males, the most common solitary appearance of the cutaneous lesions and the obvious absence of the gynaecological counterpart, make the diagnostic suspicion difficult, thus amplify the risk of a late diagnosis of a possible renal involvement. Besides surgery for large or painful lesions, nifedipine, phenoxybenzamine, nitroglycerine, doxazosin, gabapentin, topical lidocaine or capsaicin, carbon dioxide laser ablation or botulinum toxin injections, have been variously tested to improve the symptoms –.
Our observation highlights the role of dermoscopy in the diagnosis of cutaneous leiomyomas disclosing this hereditary syndrome for the risk of renal cancer and cerebral cavernomas. Dermoscopy should be performed on non-melanocytic multiple lesions mimicking leiomyomas in a large number of patients, to establish a strict classification, in order to identify false negative cases or evaluate them as dermatofibromas. The role of the dermatologist is crucial in the final diagnosis of this rare syndrome in a patient with multi organ involvement. Therefore, dermoscopy can be considered as an adjuvant tool that gives some extra information before histology.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.
The authors wish to thank Denis Mariano for editing assistance.
- Reed WB, Walker R, Horowitz R: Cutaneous leiomyomata with uterine leiomyomata. Acta Derm Venereol 1973, 53: 409–416.PubMedGoogle Scholar
- Kloepfer HW, Krafchuk J, Derbes V, Burks J: Hereditary multiple leiomyoma of the skin. Am J Hum Genet 1958, 10: 48–52.PubMedPubMed CentralGoogle Scholar
- Gardie B, Remenieras A, Kattygnarath D, Bombled J, Lefèvre S, Perrier-Trudova V, Rustin P, Barrois M, Slama A, Avril MF, Bessis D, Caron O, Caux F, Collignon P, Coupier I, Cremin C, Dollfus H, Dugast C, Escudier B, Faivre L, Field M, Gilbert-Dussardier B, Janin N, Leport Y, Leroux D, Lipsker D, Malthieu F, McGilliwray B, Maugard C, Méjean A, et al.: Novel FH mutations in families with HLRCC an patient with isolated type 2 papillary renal cell carcinoma. J Med Genet 2011, 48: 226–234. 10.1136/jmg.2010.085068View ArticlePubMedGoogle Scholar
- Alam NA, Barclay E, Rowan AJ, Tyrer JP, Calonje E, Manek S, Kelsell D, Leigh I, Olpin S, Tomlinson IP: Clinical features of multiple cutaneous and uterine leiomyomatosis: an underdiagnosed syndrome. Arch Dermatol 2005, 141: 199–206.PubMedGoogle Scholar
- Holst VA, Junkins-Hopkins JM, Elenitsas R: Cutaneous smooth muscle neoplasms: clinical features, histologic findings, and treatment options. J Am Acad Dermatol 2002, 46: 477–490. 10.1067/mjd.2002.121358View ArticlePubMedGoogle Scholar
- Cook-Norris RH, Rodriguez AO, Kovach BT, Boyd AS, Zic JA: Segmental cutaneous piloleiomyomata. Skinmed 2010, 8: 238–239.PubMedGoogle Scholar
- Ponti G, Pellacani G, Seidenari S, Pollio A, Muscatello U, Tomasi A: Cancer-associated genodermatoses: Skin neoplasms as clues to hereditary tumor syndromes. Crit Rev Oncol Hematol 2012, 07: 001.Google Scholar
- Emer JJ, Solomon S, Mercer SE: Reed's Syndrome: A case of multiple cutaneous and uterine leiomyomas. J Clin Aesthet Dermatol 2011, 4: 37–42.PubMedPubMed CentralGoogle Scholar
- Paschoal FM, Gargantini Rezze G: Dermoscopic findings in a patient with multiple piloleiomyomas. Dermatol Pract Concept 2012, 2(4):6.View ArticleGoogle Scholar
- Farache Camara M, Moura Rossiter Pinheiro P, Dantas Jales R, da Trindade Bezerra Neto P, Bastos Costa J, de Sousa VL LR: Multiple dermatofibromas: Dermoscopic patterns. Indian Journal of Dermatology 2013, 58(3):243.View ArticleGoogle Scholar
- Scope A, Benvenuto-Andrade C, Agero AL, Marghoob AA: Nonmelanocytic Lesions Defying the Two-Step Dermoscopy Algorithm. Dermatol Surg 2006, 32(11):1398–1406. 10.1111/j.1524-4725.2006.32312.xPubMedGoogle Scholar
- Smit DL, Mensenkamp AR, Badeloe S, Breuning MH, Simon ME, van Spaendonck KY, Aalfs CM, Post JG, Shanley S, Krapels IP, Hoefsloot LH, Van Moorselaar RJ, Starink TM, Bayley JP, Frank J, Van Steensel MA, Menko FH: Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis. Clin Genetics 2011, 79: 49–59. 10.1111/j.1399-0004.2010.01486.xView ArticleGoogle Scholar
- Campione E, Terrinoni A, Orlandi A, Codispoti A, Melino G, Bianchi L, Mazzotta A, Garaci FG, Ludovici A, Chimenti S: Cerebral cavernomas in a family with multiple cutaneous and uterine leiomyomas associated with a new mutation in the fumarate hydratase gene. J Invest Dermatol 2007, 127: 2271–2273. 10.1038/sj.jid.5700851View ArticlePubMedGoogle Scholar
- Christenson LJ, Smith K, Arpey CJ: Treatment of multiple cutaneous leiomyomas with CO2 laser ablation. Dermatol Surg 2000, 26: 319–322. 10.1046/j.1524-4725.2000.99250.xView ArticlePubMedGoogle Scholar
- Sifaki MK, Krueger-Krasagakis S, Koutsopoulos A, Evangelou GI, Tosca AD: Botulinum toxin type A-treatment of a patient with multiple cutaneous piloleiomyomas. Dermatol 2009, 218: 44–47. 10.1159/000173695View ArticleGoogle Scholar
- Onder M, Adiflen E: A new indication of botulinum toxin: leiomyoma-related pain. J Am Acad Dermatol 2009, 60: 325–328. 10.1016/j.jaad.2008.05.044View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-5945/14/7/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.